Laddar...
Lysin CF-301 Demonstrates In Vitro Synergy with Conventional Antibiotics against Staphylococcus aureus
BACKGROUND: CF-301 is a novel, recombinantly-produced bacteriophage-derived lysin (cell wall hydrolase) and is the first agent of this class to enter clinical development in the US for the treatment of bacteremia including endocarditis due to S.aureus. This study evaluated the in vitro activity of C...
Sparad:
| I publikationen: | Open Forum Infect Dis |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5631334/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.908 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|